Updated HR+/HER2- metastatic management.

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Hassan GHAZAL, MD, Dubai UAE, Medical Oncologist and Hematologist, Dubai, UAE

Hassan GHAZAL
MD, Dubai UAE, Medical Oncologist and Hematologist, Dubai, UAE

What’s your take on new breast cancer treatments?
Georgia DEMETRIOU
oncologist, Johannesburg, SA
VAB and VAE: To sample or to excise?
Gregory LENCZNER
What strategy to use to manage side effects in practice?
Georgia DEMETRIOU
oncologist, Johannesburg, SA
Explain us how you can use cement to generate a local immunotherapy?
Nicolas AMORETTI
How can you predict tumor behavior?
Simon NAYLER
pathologist, Johanesburgh, South Africa